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Abstract	Ten	 to	 twenty	 percent	 of	 western	 countries	 population	 suffers	 from	 Major	 Depression	Disorder	 (MDD).	 Stressful	 life	 events	 represent	 the	 main	 environmental	 risk	 factor	contributing	to	the	onset	of	MDD	and	other	stress-related	neuropsychiatric	disorders.	In	this	regard,	 investigating	 brain	 physiology	 of	 stress	 response	 underlying	 the	 remarkable	individual	 variability	 in	 terms	 of	 behavioral	 outcome,	 may	 uncover	 stress-vulnerability	pathways	 as	 a	 source	 of	 candidate	 targets	 for	 conceptually	 new	antidepressant	 treatments.	Serum	 Response	 Factor	 (SRF)	 has	 been	 addressed	 as	 a	 stress	 transducer	 via	 promoting	inherent	 experience-induced	 Immediate	Early	Genes	 (IEGs)	 expression	 in	neurons.	However,	in	 resting	 conditions,	 SRF	 also	 represents	 a	 transcriptional	 repressor	 able	 to	 assemble	 the	core	 LSD1/CoREST/HDAC2	 corepressor	 complex,	 including	 demethylase	 and	 deacetylase	activities.	We	here	show	that	dominant	negative	SRF	splicing	isoform	lacking	most	part	of	the	transactivation	 domain,	 namely	 SRFΔ5,	 owes	 its	 transcriptional	 repressive	 behavior	 to	 the	ability	 of	 assembling	 LSD1/CoREST/HDAC2	 corepressor	 complex	 meanwhile	 loosing	 its	affinity	 for	 transcription-permissive	 cofactor	 ELK1.	 SRFΔ5	 is	 highly	 expressed	 in	 the	 brain	and	developmentally	regulated.	 In	the	light	of	 its	activity	as	negative	modulator	of	dendritic	spine	 density,	 SRFΔ5	 increase	 along	 with	 brain	 maturation	 suggests	 a	 role	 in	 synaptic	pruning.	 Upon	 acute	 psychosocial	 stress	 SRFΔ5	 isoform	 transiently	 increases	 its	 levels.	Remarkably,	when	stress	is	chronically	repeated	a	different	picture	occurs	where	SRF	protein	becomes	 stably	 upregulated	 in	 vulnerable	 mice	 but	 not	 in	 resilient	 animals.	 These	 data	suggest	a	role	for	SRFΔ5	that	is	restricted	to	acute	stress	response,	while	positive	modulation	of	SRF	during	chronic	stress	matches	the	criteria	for	stress	vulnerability	hallmark.					
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Introduction	Everyday	 life	 stress	 is	 a	 critical	 risk	 factor	 toward	 the	 onset	 of	 depression	 and	 mood	disorders[1,2].	 It	 is	 commonly	 accepted	 that	 psychosocial	 stress	 specifically	 elicits	maladaptive	 structural	 neuronal	 responses	 in	 those	 susceptible	 individuals	 that	 undergo	stress-induced	depressive	traits[3-8].	In	particular,	stress	remodels	dendritic	arbor	as	well	as	spine	 shape	and	density	 in	different	brain	areas	 including,	but	not	 limited	 to	hippocampus,	amygdala	and	prefrontal	cortex	thereby	modifying	neuron	excitation	thresholds[7].	Notably,	these	different	areas	undergo	opposite	structural	changes	in	response	to	stress	synergistically	contributing	to	a	thorough	reshaping	of	affective	cortico-limbic	brain	circuitry[6].	In	general,	maladaptive	 modifications	 of	 neuronal	 morphology	 represent	 a	 footprint	 of	 stress-vulnerability;	 on	 the	 other	 side,	 resilient	 animals	 allostatically	 avoid	 the	 onset	 of	 stress-induced	 depressive	 traits	 via	 preserving	 homeostatic	 adaptation	 mechanisms[9-12].	 These	pathways	are	instrumental	to	protect	against	the	negative	effects	of	stress	via	activation	of	a	specific	 transcriptional	 program	 –involving	 proper	 control	 of	 the	 Immediate	 Early	 Genes	(IEGs)–	and	driving	engagement	of	resiliency-related	circuitry	through	dedicated	modulation	of	 neuronal	 structural	 plasticity[8,10,11,13-15].	 A	 master	 integrator	 of	 the	 transcriptional	program	 orchestrating	 IEGs	 expression	 in	 neurons	 in	 response	 to	 experience	 is	 the	transcription	factor	Serum	Response	Factor	(SRF)[16].	SRF	has	been	also	implicated	in	stress	response	as	a	mediator	of	neuronal	adaptation	underlying	resilience	to	chronic	Social	Defeat	Stress	in	the	Nucleus	Accumbens	(NAc)[13].	Moreover,	through	activity-dependent	control	of	several	IEGs,	featuring	a	Serum	Responsive	Element	(SRE)	at	the	level	of	genomic	regulatory	regions,	 SRF	 remodels	 neurons	 cytoarchitecture	 and	 morphology	 impinging	 on	 synaptic	activity	 of	 stress-responsive	 circuitry,	 thereby	 modulating	 behavioral	 outcome[13,14].	 SRF	represents	a	versatile	transcription	factor	because	of	its	ability	to	promote	transcription	upon	stimuli	and	to	function	as	a	repressor	in	resting	conditions[17,18].	Consistently,	we	show	that	
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SRF	 binds	 epigenetic	 corepressor	 Lysine	 Specific	 Demethylase	 1	 (LSD1/KDM1A)	 together	with	CoREST	and	HDAC2,	thus	recruiting	at	the	IEGs	promoters	a	core	epigenetic	corepressor	complex	 that	has	already	been	 shown	 to	exert	negative	 regulation	of	memory	and	 synaptic	plasticity	in	mice[19,20].		Interestingly,	in	the	hippocampus	a	paradigm	of	psychosocial	stress	increases	the	availability	of	corepressor	LSD1	through	a	 transcriptional	and	splicing-based	mechanism	also	 involving	downregulation	of	dominant	negative	neurospecific	LSD1	isoform	neuroLSD1[18].	It	has	been	proposed	that	reduced	IEGs	expression	in	the	hippocampus	upon	psychosocial	stress	concurs	to	 resiliency	 via	 homeostatic	 mechanisms[18,20].	 Acute	 stress-induced	 epigenetic	modifications	 in	 the	 hippocampus	 to	 concur	 to	 restrain	 IEG	 transcription	 in	 response	 to	further	stressful	experiences,	a	process	that	has	been	associated	to	maintaining	stress-related	plasticity	 and	 consequent	 memorization	 of	 the	 negative	 experience	 at	 an	 adaptive	level[12,15,18,20].	 Taking	 into	 account	 that	 most	 often,	 acute	 stress	 does	 not	 lead	 to	 long	term	 psychobiologic	 and	 behavioral	 outcomes,	 learning	 molecular	 rules	 of	 acute	 stress	response	–likely	desensitized	via	chronic	stress-related	allostatic	overload–	could	represent	a	promising	 strategy	 to	 decipher	molecular	 underpinnings	 of	 vulnerability[12].	 In	 search	 for	novel	 neurospecific	 modulators	 of	 IEG	 transcription	 in	 response	 to	 stress,	 we	 focused	 on	transcription	 factor	 SRF.	 SRF	 includes	 three	 well-characterized	 functional	 domains,	 the	MADS-box	 DNA	 binding	 domain,	 which	 is	 also	 involved	 in	 homodimerization,	 a	transactivation	 domain	 located	 at	 the	 C-terminus	 of	 the	 protein	 that	 alone	 can	 activate	transcription	of	a	reporter	gene[21]	and	a	N-terminal	portion	where	two	distinct	repressive	domains	were	mapped	and	described	as	instrumental	to	restrain	target	transcription[21,22].	SRF	 has	 been	 indeed	 described	 to	 bind	 target	 DNA	 promoters	 in	 both	 basal	 conditions,	behaving	as	a	repressor	when	the	IEGs	are	largely	silenced,	and	upon	serum-induced	activity	
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(in	proliferating	cells)	or	neuronal	activity	 in	neurons,	behaving	as	 transcriptional	activator	[23-25].	It	has	been	described	that	splicing	mechanism	leading	to	exon	E5	skipping	can	regulate	SRF	function	in	the	heart.	The	alternatively	spliced	isoform	SRFΔ5	is	a	transcription	factor	lacking	a	 substantial	part	of	 the	C-terminal	 transactivation	domain	but	 retaining	 the	ability	 to	bind	DNA.	This	splicing	 isoform	antagonizes	SRF	function	as	 transcriptional	activator,	acting	as	a	potent	repressor	of	SRF-dependent	promoters[26].	In	this	work	we	outlined	for	the	first	time	SRFΔ5	 expression	 in	 mouse	 and	 human	 brain.	 In	 the	 hippocampus	 SRFΔ5	 makes	 up	 a	substantial	amount	of	SRF	protein	isoforms,	suggesting	that	alternative	splicing	may	regulate	SRF	 function	 in	 this	 brain	 area.	 Interestingly,	 both	 SRF	 and	 SRFΔ5	 bind	 the	 transcriptional	corepressor	 complex	 LSD1/CoREST/HDAC2	 via	 their	 shared	 N-terminal	 repressor	 domain,	but	 relevantly,	 SRFΔ5	 cannot	 bind	 ELK1,	 one	 of	 the	 most	 characterized	 positive	 SRF	cofactor[27-29].	 SRF	 mainly	 regulates	 morphostructural-relevant	 transcription	 and	consistently	 SRFΔ5	 overexpression	 significantly	 reduces	 spine	 density	 in	 hippocampal	neurons.	We	propose	that	positive	and	negative	modulation	of	activity-evoked	transcription	via	SRF	and	LSD1	together	with	their	brain	enriched	splicing	isoforms,	potentially	contributes	to	shaping	psychosocial	stress	vulnerability.		
Materials	and	methods	
Protein	 Extraction,	 Western	 Blot	 and	 Immunoprecipitation.	 Experiments	 were	 performed	essentially	as	in[30,31].	Cultured	cell	lines	or	tissues	were	homogenized	as	described[32].	We	performed	 immunoprecipitation	 experiments	 and	 western	 blot	 experiments	 with	 the	following	 antibodies:	 anti-SRF	 (D71A9;	 Cell	 Signaling	 Technology);	 anti-myc	 (Abcam	Ab9106);	 anti-LSD1	 (C69G12;	 Cell	 Signaling	 Technology);	 anti-ELK1	 (9182;	 Cell	 Signaling	Technology);	 anti-Synaptophysin	 (D35E4,	 Cell	 Signaling	 Technology);	 anti-HDAC2	 (ab7029,	
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Abcam),	 anti-CoREST	 (Merck	 Millipore);	 anti-β	 Actin	 (A2228;	 Sigma-Aldrich);	 anti-HA	 (sc-805;	 Santa	 Cruz	 Biotechnology);	 anti-HA-AC	 (sc-7392;	 Santa	 Cruz	 Biotechnology);	 normal	mouse	 IgG-AC	 (sc-2343;	 Santa	 Cruz	 Biotechnology);	 goat	 anti-mouse	 IgG-HRP	 (Santa	 Cruz	Biotechnology)	and	donkey	anti-rabbit	IgG	horseradish	(ECL).	Western	 blot	 analyses	 were	 carried	 out	 using	Alliance	 Mini	 HD9	 acquisition	 system	and	NineAlliance	1D	software	(Uvitec	Cambridge,	UK).	
GST	Pull-Down.	Briefly,	 BL21	 cells	were	 CaCl2-transformed	with	pGEX-GST,	 pGEX-GST-hSRF,	pGEX-GST-hSRF∆5,	 pGEX-GST-hSRF1-171-N-term,	 pGEX-GST-hSRF339-508-C-term	 and	encoded	GST-tagged	proteins	were	 expressed,	 batch	 purified	 by	 conjugation	 to	Glutathione	Sepharose	4B	beads	(GE	Healthcare),	and	incubated	over	night	with	2	months	old	male	mice	forebrain	 extracts	 obtained	with	 a	 low	 stringency	 buffer.	 GST	 pull-down	 experiments	were	performed	as	in[33]	
Plasmids.	 For	 coimmunoprepitation	 experiments:	 pCGN-HA-hSRF∆5	 was	 obtained	 from	pCGN-HA-hSRF	 (Addgene,	 11977)	 by	 site-specific	 mutagenesis	 using	 the	 Q5	 Site-Directed	Mutagenesis	 Kits	 (New	 England	 BioLabs,	Massachusetts,	 USA);	myc-hSRF	 and	myc-hSRF∆5	were	 obtained	 by	 subcloning	 hSRF	 and	 hSRF∆5	 into	 pcDNA3.1-myc/His	 (-).	 For	 GST	 Pull-down:	 pGEX-hSRF1-171	 was	 obtained	 from	 pCGN-HA-hSRF	 by	 site-specific	 mutagenesis	introducing	 a	 stop	 codon	 after	 amino	 acid	 171	 and	 then	 subcloning	 it	 into	 pGex	 plasmid;	pGEX-hSRF339-508-C-term	 was	 generated	 by	 PCR	 using	 pCGN-HA-hSRF	 as	 template	 and	cloned	in	XbaI	site	in	pCGN-HA	vector,	introducing	a	NLS	in	frame	with	the	coding	sequence,	and	then	subcloning	it	into	pGEX	plasmid.		For	primary	neurons	transfection:	myc-fused	SRF	and	SRF∆5	(pCDNA3.1-myc/His-hSRF	and	pCDNA3.1-myc/His-hSRF∆5)	were	 generated	 by	 PCR	 using	 pCGN-vectors	 as	 templates	 and	cloned	 into	 expression	 vector	 pCDNA3.1-myc/His	 in	 the	 EcoRI	 and	BamHI	 sites;	 pEGFP-N1	
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was	obtained	 from	Addgene.	 pEGFP-N1	 construct,	 supplied	by	Addgene,	was	 transfected	 to	mark	the	entire	neuronal	cell.	All	plasmids	were	sequenced.	
Total	RNA	Extraction,	qRT-PCR	Analysis,	and	rqfRT-PCR.	 TRIzol	 reagent	 (Sigma-Aldrich)	 was	used	 for	 total	 RNA	 isolation	 from	 hippocampal	 extract.	 Any	 residual	 DNA	 was	 removed	treating	 the	 purified	 RNA	 with	 RNase-free	 DNase	 set	 (Qiagen).	 qRT-PCR	 analysis	 was	performed	 as	 described	 elsewhere[34].	 Expression	 of	 SRF	 isoforms	 was	 normalized	 on	Ribosomal	protein	SA	(RPSA).	RqfRT-PCR	was	used	to	measure	exon	E5	splicing	inclusion	in	mature	 SRF	 endogenous	 transcripts,	 as	 described	 for	 LSD1[35]	 Thanks	 to	 the	 annotated	primers	 (Supplemental	material)	we	 obtained	 two	PCR	products	 that	 have	 been	 scored	 for	displaying	 identical	 amplification	 efficiency	 with	 qRT-PCR.	 A	 common	 forward	 primer	 has	been	 designed	 on	 exon	 E4,	 and	 two	 reverse	 primers,	 the	 former	 (specific	 for	 SRF)	 was	designed	on	exon	E4-E5	splicing	junction,	and	the	latter	(specific	for	SRFD5)	was	designed	on	exon	E4-E6	splicing	junction.	
Primary	hippocampal	neuronal	cultures.	Primary	 hippocampal	 neurons	were	 prepared	 from	embryonic	 days	 18-19	 rat	 brains[36]	 and	 plated	 on	 coverslips	 coated	 with	 poly-L-lysine	(50μg/ml)	at	75.000/well	for	immunochemistry.	Cultured	neurons	were	cotransfected	using	the	 calcium	 phosphate	method	 as	 described	 in[37].	 Immature	 neurons	were	 transfected	 at	DIV4	and	fixed	at	DIV8-18.	
Proteasome	inhibition.	DIV12	primary	rat	hippocampal	neurons	were	treated	with	MG-132	for	proteasome	inhibition.	20	µM	MG-132	(Sigma-Aldrich)	was	added	to	the	medium.	Untreated	samples	were	 incubated	with	the	drug	solvent	(DMSO). Protein	extraction	was	performed	after	2,5	hours	of	treatment.	
Morphological	 and	 spine	 density	 analyses.	 Neuronal	 cells	 were	 fixed	 with	 4%	paraformaldehyde/4%	 sucrose	 at	 DIV8	 for	 morphological	 analysis	 and	 at	 DIV18	 for	 spine	density	evaluation.	Images	were	acquired	by	confocal	microscopy.	Morphological	analysis	was	
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performed	using	the	Sholl	analysis	module	in	Fiji	software,	while	spine	density	was	evaluated	with	NeuronStudio	software.		
Chemical	 LTP	 (cLTP).	 Primary	 rat	 hippocampal	 neurons	 were	 treated	 for	 chemical	 LTP	 at	DIV18.	Ten	minutes	before	stimulation	the	medium	was	replaced	by	pre-warmed	Stimulation	solution	(3	µM	strychnine,	20	µM	bicuculline)	in	Extracellular	solution	(140mM	NaCl,	1,3	mM	CaCl2,	5mM	KCl,	25	mM	HEPES,	33mM	glucose).	 cLTP	was	 induced	with	200	µM	glycine	at	37°C.	After	3	minutes	the	Stimulation	solution	was	removed	and	replaced	with	pre-warmed	Extracellular	 solution.	 Neurons	were	 fixed	 2	 hours	 after	 and	 analyzed	 for	 spine	 density	 as	previous	described.		
Experimental	Animals.	10-weeks-old	male	C57BL/6N	wild-type	mice	were	used	and	they	were	housed	 individually	 throughout	 the	 testing	period	with	 free	 access	 to	 food	and	water.	Mice	lived	in	controlled	temperature	(20–22	°C)	with	a	12-h	light/dark	cycle	(lights	on	at	7:00	AM).	All	experimental	procedures	entailing	the	use	of	rodents	followed	the	guidelines	established	by	the	Italian	Council	on	Animal	Care	(Legislative	Decree	no.	26,	March	2014)	and	European	regulations	(2010/63/UE)	and	were	approved	by	Italian	Ministry	of	Health.	Every	experiment	was	made	to	minimize	the	number	of	mice	used	and	their	suffering.	We	strictly	followed	these	current	rules	and	regulations	regarding	animal	treatment	during	all	the	procedures.	
Acute	Social	Defeat	Stress	(ASDS).	We	used	a	modified	protocol	 of	 the	 SDS	 test[18].	 In	 short,	CD1	aggressor	mice	were	used	to	defeat	10-weeks-old	C57BL/6N	wild-type	mice	in	a	single	session	 of	 SDS.	 The	 experimental	 mouse	 was	 exposed	 to	 a	 CD1	 aggressor	 mouse	 for	 5	minutes.	 After	 the	 physical	 contact	 the	 two	mice	were	 separated	 by	 a	 perforated	 Plexiglas	divider	 and	 the	 stress	 continued	 in	 its	 psychological	 form	 through	 visual	 and	 olfactory	interactions	with	the	aggressor.	In	ASDS	test	the	control	mice	were	housed	(two	per	cage)	in	the	 opposite	 sides	 of	 Plexiglas	 divider	 in	 cages	 identical	 to	 those	 of	 experimental	 mice.	Respectively	after	2	or	7	hours	of	physical	contact,	the	molecular	analyses	were	performed	in	
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both	of	control	and	stressed	mice.	Animals	were	also	analyzed	24	hours	after	the	cease	of	a	7	hours-long	acute	psychosocial	stress.	
Chronic	Social	Defeat	Stress.	 We	 employed	 a	 standardized	 protocol	 of	 CSDS,	 able	 to	 induce	long-lasting	 depression-like	 phenotype	 with	 anhedonia,	 anxiety	 and	 social-avoidance	behaviors[5,38].	Briefly,	aggressive	CD1	retired	breeder	mice	were	used	to	defeat	8/9	weeks	old	 C57BL/6	 mice.	 C57BL/6	 mice	 were	 put	 in	 direct	 contact	 for	 6,5	 min/day	 over	 10	consecutive	days	to	a	novel	CD1	aggressor.	After	 the	6,5	min	physical	contact,	experimental	mice	and	CD1	aggressor	were	 separated	by	a	perforated	Plexiglas	divider	 in	order	 to	allow	sensory	 interaction,	 in	 the	 context	 of	 limiting	 potential	 physical	 damages	 to	 the	 smaller	intruder	 mice.	 Non-defeated	 control	 C57BL/6	 mice	 were	 housed	 (two	 per	 cage)	 in	 the	opposite	side	of	divided	cages	identical	to	those	used	for	the	defeat.	24	hours	after	the	cease	of	CSDS,	defeated	and	control	mice	were	subjected	 to	 the	social	 interaction	 test	 to	measure	social	avoidance.	In	the	first	part	of	the	test	each	mouse	was	placed	in	a	square	arena	(40	x	40	cm)	with	 an	 empty	 small	 cage	 for	 2,5	min.	 In	 the	 second	 part	 of	 the	 test	 each	mouse	was	placed	back	in	the	arena	for	2,5	min	but	with	an	unfamiliar	CD1	mouse	inside	the	small	cage.	The	 social	 interaction	 ratio	 (SIR,	 i.e.	 time	 spent	 in	 the	 interaction	 zone	with	 the	 novel	 CD1	mouse	 present/	 time	 spent	 in	 interaction	 zone	 without	 the	 CD1	 mouse)	 was	 calculated.	Control	 mice	 usually	 have	 a	 SIR	 >1.	 Defeated	 mice	 with	 a	 SIR<0,8	 were	 considered	 as	susceptible	 (SUS),	while	 defeated	mice	 that	 showed	 a	 SIR>1,2	were	 considered	 as	 resilient	(RES).	48	hours	after	the	cease	of	CSDS,	mice	were	sacrificed	and	hippocampal	areas	collected	for	 RNA	 and	 protein	 analysis.	 We	 started	 from	 a	 total	 number	 of	 48	 mice.	 24	 mice	 were	stressed	and	24	were	used	as	controls.	Of	the	24	controls	we	selected	7	mice	with	SIR>1,2.	Of	the	24	stressed	mice,	17	were	further	analyzed	for	SIR.	10	were	RES	and	7	were	SUS[5].	We	excluded	3	RES	with	1<SIR<1,2	and	1	SUS	with	0,8<SIR<1.	
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Data	Analysis	and	Statistical	Methods.	We	used	the	minimum	number	of	animals	predicted	by	statistical	sample	size	determination	analyses	using	the	following	parameters:	POWER	0.8;	α	0.05;	 β0.2.	Data	 are	 shown	as	means	±	 SEM.	The	 statistical	 analyses	were	performed	using	unpaired	Student’s	t	test	for	single	comparisons	and	one-way	or	two-way	ANOVA	for	multiple	comparisons	with	PRISM	6.0	software	(GraphPad).		
Results	
1.	 SRFD5	 is	 enriched	 in	 the	 brain	 and	 developmentally	 regulated	 in	 the	 mouse	
hippocampus	SRF	repressive	activity	has	been	mapped	and	functionally	characterized	within	the	N-terminal	domain[21].	For	instance,	prototypical	SRF	target	c-fos,	is	not	only	transactivated	in	response	to	 stimuli	 but	 also	 actively	 repressed	 in	 basal	 conditions	 with	 the	 contribution	 of	SRF[21,22,39].	This	state	of	repression	can	be	referred	to	as	poised	repression[22]	and	is	at	least	 in	 part	 mediated	 by	 SRF	 ability	 to	 recruit	 a	 structured	 HDAC-containing	complex[18,40,41],	among	which	the	LSD1/CoREST/HDAC2	corepressor	complex[18].		We	 previously	 observed	 that,	 also	 in	 the	 brain,	 SRF	 protein	 is	 present	 in	 two	 distinct	isoforms,	the	canonical	full-length	protein	of	508	amino	acids	with	an	electrophoretic	mobility	at	67	KDa	and	a	specific	and	faster	migrating	band	at	57	KDa,	the	expected	molecular	weight	of	SRFD5[18].	Note	that	it	has	recently	been	shown	that	in	the	mouse	brain,	knocking	down	SRF	 entails	 loss	 of	 both	 bands[42].	 SRF	 gene	 undergoes	 different	 events	 of	 alternative	splicing;	 therefore	we	 further	 investigated	 the	origin	of	p57	band	as	a	predicted	alternative	splicing	 isoform.	 In	 Fig.	 1A	 the	 alternative	 splicing	 events	 generating	 SRF	 and	 SRFD5	 are	schematized.	We	compared	the	expression	of	the	two	SRF	protein	isoforms	in	mouse,	rat	and	human	hippocampus	as	well	as	in	neuronal	and	non-neuronal	cell	lines	(Fig.	1B).	Migration	of	recombinant	 myc-tagged	 SRF	 and	 SRFD5	 fusion	 proteins	 overexpressed	 in	 Neuro2a	
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neuroblastoma	cell	line,	recapitulates	the	hippocampal	endogenous	SRF	and	SRFD5	SDS-PAGE	immunoreactivity	 profile	 (Fig.	 1B).	 In	 order	 to	 unambiguously	 define	 that	 SRF	 p57	corresponded	 to	 SRFD5,	we	 performed	 a	RT-PCR	 on	 different	mouse	 tissues	 using	 primers	able	 to	generate	 two	families	of	SRF-related	amplicons	–including	and	skipping	exon	E5–	 in	the	same	semi-quantitative	PCR	assay.	These	primers	anneal	on	SRF	exon	E4	and	E6	thereby	generating	 amplicons	 of	 different	 molecular	 weight.	 As	 shown	 in	 Fig.	 1C	 the	 upper	 band,	corresponding	 to	 full-length	 SRF	 was	 highly	 prevalent	 in	 non-neuronal	 tissues.	 On	 the	contrary,	the	lower	amplicon	predicted	to	belong	to	SRFD5	was	expressed	in	the	forebrain	as	well	as	in	different	brain	areas,	similarly	to	SRF.	Notably,	sequence	analysis	of	the	lower	band,	confirmed	 the	 presence	 of	 expected	 junction	 between	 exons	 E4	 and	 E6,	 ultimately	demonstrating	 that	 this	band	originates	 from	SRFD5	(Fig.	1D).	A	more	quantitative	analysis	based	on	relative	quantity	fluorescent	PCR	(rqfRT-PCR[35])	of	SRF	and	SRFD5	splicing	ratios	has	 been	 performed	 by	 using	 a	 specific	 set	 of	 three	 primers	 generating	 two	 amplicons	comparable	 in	 length	 (a	 first	which	 is	 specific	 for	 SRF	 and	 a	 second	 for	 SRFD5).	With	 this	approach	we	further	confirmed	the	preferential	brain	expression	of	SRFD5	compared	to	other	tissues	(Fig.	1E).		Next,	 using	 the	 same	 rqfRT-PCR	 technique	 we	 characterized	 SRFD5	 expression	 during	development	 in	 the	 mouse	 hippocampus,	 in	 parallel	 with	 SRF	 (Fig.	 1F).	 As	 shown,	 SRFD5	relative	mRNA	 level	 remains	 stable	 from	PN	9-15	 to	 adulthood	 (months	 7-12).	 Conversely,	SRFD5	protein	 level	 increases	during	development	 in	the	mouse	hippocampus,	representing	30%	of	 all	 SRF	proteins	 at	 the	 perinatal	window	 (PN1-8	 Fig.	 1G),	 and	 increasing	 to	 almost	50%	 during	 adulthood	 (MO7-12	 Fig.	 1G).	 This	 weak	 correspondence	 between	 RNA	 and	protein	 levels	along	with	aging	suggests	that	post-translational	differences	between	the	two	SRF	isoforms	may	occur,	possibly	related	to	differential	half-life	between	the	two	proteins.	In	this	 regard	we	 analyzed	 susceptibility	 to	 proteasomal	 degradation	 of	 endogenous	 SRF	 and	
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SRFD5	 using	mature	 primary	 hippocampal	 neurons.	 As	 shown	 in	 Fig.	 1H	 only	 SRF	 showed	significant	 increase	 upon	 2,5	 hours	 proteasome	 inhibition	 with	 MG-132.	 On	 the	 contrary,	SRFD5	 does	 not	 change	 its	 levels	 in	 these	 experimental	 conditions,	 escaping	 proteasome	degradation.	 This	 result	 provides	 a	 possible	 reason	 why	 in	 basal	 conditions,	 in	 the	 adult	hippocampus,	to	a	relative	level	of	20%	for	SRFD5	encoding	mRNA	and	80%	SRF,	the	protein	levels	of	the	two	isoforms	are	almost	equally	expressed.		
2.	SRFD5	cannot	bind	ELK1	in	the	brain	but	retains	the	ability	to	recruit	the	corepressor	
complex	LSD1/CoREST/HDAC2.	SRFD5	has	been	described	as	an	inhibitor	of	SRF-dependent	transcriptional	activity,	because	it	lacks	a	significant	portion	of	the	transactivation	domain	at	the	C-terminal	(largely	encoded	by	exon	E5)	but	maintains	the	ability	to	bind	these	responsive	elements	at	the	DNA	level[26].		We	then	probed	SRF	association	with	ELK1,	long-known	positive	SRF	coregulator	responsive	to	MAPK	pathway[29].	To	this	aim,	we	performed	GST	pull-down	experiments	using	purified	recombinant	GST-tagged	SRF	and	SRFD5	expressed	in	E.	coli	incubated	with	mouse	forebrain	protein	 extracts.	 As	 expected,	 GST-SRF	 can	 recruit	 ELK1[43];	 on	 the	 contrary,	 using	recombinant	GST-SRFΔ5	as	a	bait,	ELK1	is	barely	detectable	by	western	blot	analysis	(Fig.	2C).	We	 then	decided	 to	evaluate	 the	ability	of	 SRFD5	 to	bind	 the	epigenetic	 corepressors	LSD1	and	 CoREST,	which	 have	 been	 demonstrated	 to	 be	 important	 to	 regulate	 SRF	 target	 genes	transcriptional	 modulation	 in	 the	 hippocampus[18,34,44].	 LSD1,	 as	 well	 as	 HDAC2	 and	CoREST	are	all	recruited	by	SRF	and	SRFΔ5	(Fig.	2D).	To	better	characterize	the	SRF	domain	involved	in	the	interaction	with	LSD1,	we	generated	the	GST-tagged	SRF	N-terminus	(N-SRF,	amino	acids	1-171),	containing	annotated	repressive	domains[21]	as	well	as	GST-tagged	SRF-C-terminus	 (C-SRF,	 amino	 acid	 339-508)(Fig.	 2A).	 As	 displayed	 in	 Figure	 2D,	 N-SRF	 is	sufficient	to	pull-down	the	whole	LSD1	corepressor	complex.	Synaptic	protein	synaptophysin	
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(Syp)	was	used	as	negative	control.	Thanks	to	these	experiments	a	picture	emerges	in	which	SRFD5	looses	the	ability	to	bind	positive	coregulator	ELK1	while	retaining	binding	specificity	for	corepressors,	at	 least	 in	part	 justifying	why	SRFD5	has	been	previously	defined	as	a	SRF	dominant	negative	splicing	isoform[26].	Given	the	capability	of	MADS-box	domains	of	SRF	to	constitutively	form	homodimers,	we	next	scored	 the	 ability	 of	 SRFD5	 to	 heterodimerize	 with	 SRF	 thus	 increasing	 the	 probability	 of	SRFD5	to	modulate	SRE-containing	promoters	in	accordance	to	its	cellular	amount,	relative	to	SRF.	 In	 particular	we	 took	 advantage	 of	 differently	 tagged	 SRF	 isoforms	 overexpression	 in	Neuro2a,	 showing	 by	 coimmunoprecipitation	 experiments	 that	 HA-tagged	 SRF	 can	 interact	with	myc-SRFD5	and	that	HA-tagged	SRFD5	binds	to	myc-SRF	(Fig.	2E).		
3.	SRFD5	is	a	negative	regulator	of	dendritic	spine	density	in	hippocampal	neurons	SRF	is	known	to	represent	a	master	regulator	of	neuronal	structural	plasticity	by	virtue	of	its	ability	 to	 guide	 a	 transcriptional	 program	 of	 gene	 expression	 aimed	 at	 regulating	 actin	dynamics[17,45,46].	 To	 assess	 neuroplastic	 implications	 of	 SRFD5	 in	 primary	 hippocampal	neurons	we	overexpressed	recombinant	myc-tagged	SRF	and	SRFD5	vectors	along	with	GFP,	and	analyzed	neurites	arborization	at	day	 in	vitro	8	 (DIV8)	during	 in	vitro	maturation,	 and	spine	density	 in	more	mature	neurons	at	DIV18	using	confocal	microscopy.	These	 two	time	frames	have	to	be	related	to	different	phases	of	neuronal	in	vitro	maturation	characterized	by	initial	massive	morphology-related	neurites	growth	(DIV0-DIV12),	followed	by	the	process	of	spinogenesis,	 that	 represents	 an	 optimal	 window	 to	 assess	 spine	 density	 (DIV12-DIV18).	Using	 Sholl	 analysis	 we	 outlined,	 in	 neurons	 transfected	 with	 SRFD5	 compared	 to	 GFP	cotransfected	with	pCDNA3.1	empty	vector,	a	 tendency	to	simplified	neurite	arborization	 in	terms	 of	 diminished	 number	 of	 dendritic	 branches.	 This	 tendency	 becomes	 significant	 by	means	of	 two-way	ANOVA	 test	 at	 distances	 from	 the	 soma	higher	 than	160	μm,	 suggesting	
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largely	preserved	number	of	primary	dendrite	and	decreased	arborization	of	apical	dendrites	(Fig.	 3A).	 Conversely,	 overexpression	of	myc-SRF	 ensued	 little	 or	no	 effect	when	 compared	with	control	conditions.		For	 what	 concerns	 dendritic	 spine	 analysis,	 performed	 in	 mature	 neurons	 at	 DIV18,	overexpression	of	SRFD5	caused	a	strong	decrease	in	dendritic	spine	density	with	respect	to	neurons	overexpressing	GFP	along	with	pCDNA3.1	empty	vector.	 It	 is	 true	 that	 in	 the	same	conditions,	also	SRF	overexpression	led	to	reduction	of	spine	density.	However,	the	effect	of	SRFD5	 is	 significantly	 stronger	 compared	 to	 the	one	of	 SRF	 (Fig	3B).	These	 results	 indicate	that	 in	 resting	 conditions	 both	 SRF	 and	 SRFD5	 act	 as	 negative	 modifiers	 of	 spines-related	structural	 plasticity.	 This	 result	 only	 apparently	 contrasts	 previous	 data	 scoring	 SRF	 as	 a	positive	 regulator	 of	 spine	 density[46].	 Indeed,	 to	 our	 knowledge,	 we	 are	 the	 first	 to	overexpress	 full	 length	 SRF	 in	 neurons	 to	 evaluate	 spine	density	 in	 basal	 conditions.	 Every	other	 work	 describing	 SRF	 as	 a	 positive	 spine	 regulator	 either	 used	 overexpression	 of	 a	constitutively	 active	 SRF	 (gain-of-function	 generated	 by	 fusing	 SRF	 with	 potent	 VP16	transactivation	domain)[46,47],	 or	performed	 the	experiments	upon	conditions	of	neuronal	activation[48].		Anyway,	 best-characterized	SRF	 function	 is	 to	promote	 transcription	 in	 response	 to	 stimuli	allowing	neuroplastic	changes	concurring	to	memory	formation	and	consolidation[17,24,25].	For	 this	 reason	 we	 further	 analyzed	 the	 role	 of	 SRFD5	 compared	 to	 SRF	 upon	 neuronal	activity.	It	is	widely	recognized	that	long-term	potentiation	(LTP)	of	synaptic	efficacy	entails	growth	as	well	as	 increased	number	of	dendritic	spines	 in	stimulated	neurons,	processes	 in	which	SRF	has	been	proposed	to	play	an	active	role[46,49-53].	Structural	substrates	of	LTP	in	terms	 of	 morphological	 processes	 aimed	 at	 inherently	 changing	 the	 shape	 and	 number	 of	dendritic	spines	are	well	recapitulated	in	vitro	by	the	chemical	version	of	LTP	(cLTP)[54-56],	that	 is	 pharmacologically	 induced	 via	 administration	 of	 the	 NMDAR	 co-agonist	 Glycine	 to	
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primary	 neuron	 cultures	 (see	methods)[56].	 In	 hippocampal	 neurons,	we	 transfected	myc-SRF,	myc-SRFD5	 or	 the	 empty	 vector	 pCDNA3.1	 together	with	 GFP	 at	 DIV8	 and	 preformed	cLTP	 at	 DIV18.	 Dendritic	 spine	 density	 was	 scored	 after	 2	 hours	 of	 cLTP	 with	 confocal	imaging.	 As	 shown	 in	 Fig.	 3C,	 SRFD5	 overexpression	 hampers	 cLTP-induced	 increase	 of	dendritic	 spine	 density,	 which	 remains	 evident	 instead	 in	 both	 empty	 vector	 and	myc-SRF	transfected	neurons.	These	data,	together	with	those	presented	in	figure	3B,	show	that	while	SRF	 upon	 a	 paradigm	 of	 neuronal	 activation	 can	 change	 its	 activity	 from	 repressing	 to	promoting	new	spine	formation,	SRFD5	preserves	its	negative	structural	function	regardless	the	presence	or	absence	of	a	specific	stimulus.			
4.	Acute	psychosocial	stress	modifies	SRF/SRFD5	mRNA	and	protein	ratios	Given	that	SRFD5	displays	a	clear	behavior	as	synaptic	restrainer	(Fig.	3),	we	asked	whether	the	expression	 levels	of	SRF	 isoforms	and	 the	ratio	between	SRF	and	 its	dominant	negative	isoform	 SRFD5	 could	 be	 affected	 in	 response	 to	 psychosocial	 stress.	 Indeed,	 the	 search	 for	molecular	mechanisms	linking	environmental	stress	to	modification	of	structural	plasticity	in	corticolimbic	 brain	 regions	 important	 to	 emotion	 and	 cognition-relevant	 information	processing	 has	 not	 yet	 fully	 clarified	 the	 nature	 of	 involved	 pathways[6].	 To	 this	 aim	 we	performed	 a	 paradigm	 of	 psychosocial	 stress,	 the	 acute	 social	 defeat	 stress	 (ASDS)	 in	wild	type	mice[18]	and	measured	SRF	and	SRFD5	mRNA	and	protein	 levels	during	the	phases	of	stress	 administration	 2,	 7	 and	 24	 hours	 after	 the	 end	 of	 the	 paradigm	 (Fig.	 4A-B).	Interestingly,	we	show	that	after	2	and	7	hours	of	psychosocial	stress	total	SRF	mRNA	does	not	 vary,	 whereas	 after	 2	 hours,	 the	 relative	 ratio	 between	 SRF	 and	 SRFD5	 transcripts	decreases.	 This	 splicing	 modulation	 favors	 the	 expression	 of	 SRFD5	 protein,	 whose	 levels	significantly	 increased	 compared	 to	 controls	 two	 hours	 after	 the	 beginning	 of	 the	 stress	paradigm	 (Fig.	 4B,	 right	 panel).	 Notably,	 SRFD5	 stress-induced	 increase	 at	 both	mRNA	 and	
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protein	level	is	transient,	as	24	hours	after	the	end	of	the	stress	it	returns	to	basal	levels.	On	the	contrary,	SRF	protein	does	not	change	 its	 levels,	as	 the	small	 tendency	 to	 increase	does	not	reach	statistical	significance	(Fig.	4B).	In	order	to	gain	insight	into	acute	and	transient	SRFD5	increase	two	hours	after	the	beginning	of	the	stress	paradigm,	we	measured	activity-induced	expression	of	three	IEGs,	egr1,	c-fos	and	
npas4,	which	represent	SRF	elective	targets.	As	expected,	these	targets	peak	after	2	hours	and	notwithstanding	the	stress	continuation,	at	7	hours	their	mRNA	returns	to	basal	levels.	In	this	frame,	it	is	interesting	to	note	that	the	kinetic	of	SRFD5	increase	coincides	with	the	decreasing	levels	of	its	targets	(Fig.	4C).	It	has	been	recently	proposed	that	LTD-like	decrease	of	synaptic	transmission	 in	 response	 to	 psychosocial	 stress	 at	 the	 level	 of	 the	 ventral	 hippocampus	represents	a	resiliency-like	physiological	 traits	 that	correlates	with	decreased	expression	of	the	 IEGs	 egr1	and	c-fos,	which	 is	 restricted	 to	 resilient	mice[8,10].	 In	 this	 light,	 our	 results	point	to	a	protective	role	of	SRFD5	increase	upon	acute	psychosocial	stress.		
5.	SRF	upregulation	in	the	hippocampus	is	a	hallmark	of	chronic	stress	susceptibility	SRF	 has	 already	 been	 suggested	 to	 be	 involved	 not	 only	 as	 transducer	 of	 stressful	stimuli[13,14,18],	but	also	as	a	stress	response	modifier	thanks	to	the	possibility	to	adjust	its	level	 and	 activity	 in	 response	 chronic	 stressful	 experiences	 in	 human	 and	 rodents[13].	Our	data,	 obtained	 upon	 acute	 psychosocial	 stress,	 showing	 a	 transient	 splicing	 modulation	increasing	SRFD5	protein	 level,	 suggest	 a	 further	 layer	of	 SRF	 stress-induced	 regulation.	As	acute	stress-induced	modifications	might	be	predictive	stress-coping	mechanisms	potentially	corrupted	by	chronic	stress[12,57],	we	decided	to	investigate	a	possible	involvement	of	these	transcription	 factors	 in	 hippocampal	 stress	 vulnerability	 pathways	 by	 applying	 the	 chronic	version	of	social	defeat	stress	(CSDS).	After	ten	days	of	CSDS,	traits	of	psychopathology	and	in	particular	depressive-like	behavior	were	 assessed	by	means	of	 decreased	 social	 interaction	
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ratio	 (SIR)	 [5].	 Social	 interaction	 test	was	 performed	 24	 hours	 after	 the	 cessation	 of	 CSDS,	considering	 as	 SUS	 those	 mice	 that	 showed	 a	 SIR<0.8	 and	 RES	 those	 with	 a	 SIR>1.2.	Susceptibility-related	 SIR	 values	 have	 been	 widely	 associated	 to	 depression-related	behavioral	abnormalities[10,58].	48	hours	after	the	end	of	the	CSDS,	mice	were	sacrificed	and	RNA	and	protein	analysis	 in	 the	hippocampus	was	carried	out.	 In	RES	mice	SRF	and	SRFD5	mRNA	 and	 protein	 levels	 were	 unmodified	 and	 very	 similar	 to	 those	 observed	 in	 control	animals,	 as	 well	 as	 the	 relative	 amount	 of	 SRF	 splicing	 isoforms	 (Fig.	 5A-B).	 In	 RES	 mice,	phenotypical	 absence	 of	 depressive-like	 social	 avoidance	 (SIR>1.2),	 correlates	 with	unmodified	basal	levels	of	IEGs	in	the	hippocampus	(Fig.	5C).	Interestingly,	in	SUS	animals	we	confirmed	the	molecular	signature	of	increased	basal	levels	of	c-fos,	egr1	and	npas4[10]	which	has	 been	 recently	 proposed	 as	 possible	 read-out	of	 pathogenically	 increased	 excitability	 of	this	brain	structure[8].	In	SUS	mice,	total	SRF	mRNA	was	increased	indicating	a	sustained	SRF	transcription	reflecting	significant	upregulation	of	SRF	protein	and	only	a	tendency	towards	increased	SRFD5	protein	(Fig.5A-B).	Note	that	SRF	splicing	was	unchanged.	These	data	suggest	 that	only	 in	SUS	mice	SRF	expression	undergoes	modification	in	response	to	chronic	stress	and	that	this	modulation	has	 a	 transcriptional	 nature.	 In	 this	 frame	 an	 increase	 of	 SRF	 transcription	 in	 a	 context	 of	unchanged	SRF/SRFD5	protein	ratio	is	consistent	with	increasing	overall	SRF	transcriptional	activity	 towards	 its	 targets,	 again	 compatible	 with	 concomitant	 upregulation	 of	 the	 IEGs.	Thus,	SRF	function	is	modified	by	both	acute	and	chronic	stress	but	with	different	functional	relevance,	 likely	 homeostatic	 in	 response	 to	 acute	 stress	 and	 potentially	 pathogenic	 in	response	to	chronic.				
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Discussion	SRF	actually	represents	one	of	 the	most	studied	regulators	of	activity-induced	 transcription	impacting	neurostructural	plasticity[17,45,59,60].	It	also	appears	as	a	mediator	of	the	impact	that	 environmental	 stimuli	 exert	 on	 brain	 circuitry	 [13,18].	 SRF	 function	 was	 previously	shown	 to	be	 regulated	by	alternative	 splicing.	 In	particular,	 SRFD5	 skipping	exon	5,	 acts	 as	dominant	 negative	 isoform	by	 inhibiting	 SRE-dependent	 promoter	 activity	 in	 non-neuronal	tissues[26].	 We	 present	 evidences	 that	 SRFD5	 is	 also	 highly	 expressed	 in	 the	 mammalian	hippocampus.	 In	 the	 brain,	 while	 SRFD5	 cannot	 bind	 SRF	 coregulator	 ELK1,	 it	 retains	 the	ability	to	behave	as	a	transcriptional	repressor,	a	relevant	function	displayed	by	SRF	in	basal	conditions.	Indeed,	both	SRF	and	SRFD5	bind	the	LSD1/CoREST/HDAC2	corepressor	complex	thanks	 to	 their	 N-terminal	 segment,	 already	 identified	 as	 a	 functional	 SRF	 repressive	domain[21].	Note	 that	 this	domain	 includes	at	 least	 two	phosphorylation	sites,	described	as	important	 to	 modify	 DNA	 binding	 properties	 (Ser103	 in	 human)[61],	 along	 with	transactivation	activity	(Ser228,	in	human)[43].	It	would	be	very	interesting	to	study	whether	phosphorylation	at	these	sites	modifies	SRF	interaction	with	LSD1.	From	the	functional	point	of	view,	SRF	and	SRFD5	overexpression	 in	primary	neurons	has	a	clear	 impact	on	dendritic	spines	 plasticity.	 In	 particular,	 in	 basal	 conditions	 their	 common	 ability	 to	 recruit	 a	corepressor	complex	correlates	with	a	definite	behavior	as	dendritic	spines	restrainers.	Vice	
versa,	upon	neuronal	activity	SRF	and	SRFD5	functions	diverge.	SRF,	consistently	with	its	role	as	plasticity	genes	transcriptional	activator,	endorse	cLTP-induced	 increase	of	spine	density	while	 SRFD5	 opposes	 proplastic	 impact	 of	 this	 in	 vitro	 paradigm,	 inhibiting	 new	 spines	formation.	These	evidences	sheds	a	renewed	light	on	the	 important	role	played	by	SRF	as	a	negative	regulator	of	transcription	in	resting	conditions	also	via	LSD1	partnership.	This	role	was	 reportedly	 proposed[17,18,21,40]	 and	 we	 here	 suggest	 should	 be	 considered	 as	important	 as	 the	 classical	 view	 of	 SRF	 as	 an	 activity-dependent	 transcription	 inducer	 in	
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neurons.	 In	 this	 regard	 it	 will	 be	 very	 interesting	 to	 understand	 the	 potential	 impact	 of	repression-deficient	SRF	mutants.	Indeed,	as	many	brain	diseases	including	epilepsy,	autism	spectrum	 disorders	 (ASD)	 and	 depression,	 share	 increased	 excitability	 of	 selected	 brain	areas[8,10,62,63],	 a	 role	 for	 SRF/SRFD5	 could	 be	 envisaged	 in	 the	 pathogenesis	 or	 as	 a	potential	therapeutic	target.	Environmental	stress	is	well	known	to	select	two	typologies	of	individuals,	those	that	appear	to	be	susceptible	in	the	long	run,	developing	emotional	and	affective	dysfunctions,	and	those	who	 neutralize	 the	 negative	 effects	 of	 stress	 in	 the	 frame	 of	 a	 resilient	 phenotype.	 On	 a	cellular	 and	 circuitry	 point	 of	 view	 these	 two	 categories	 differ	 in	 terms	 of	 neurostructural	plasticity	 modifications	 –spine	 density	 and	 dendrite	 branching–	 in	 different	 brain	 areas,	including	 the	 hippocampus,	 that	 participate	 to	 stress	 response[6,64].	 In	 particular,	 a	 novel	remarkable	 finding	 about	 neurobiology	 of	 stress-vulnerability	 reveals	 that	 augmented	excitability	 of	 the	 hippocampus,	modifying	 input/output	 ratio	 at	 the	 neuronal	 level	 can	 be	related	 to	depressive	 traits	 induced	by	 chronic	 stress	 in	 susceptible	 individuals[8,10].	 Such	enhanced	hippocampal	excitability	was	 functionally	associated	to	 increased	IEGs	expression	in	the	hippocampus	of	susceptible	mice,	a	finding	that	we	also	confirmed	in	this	work,	further	supporting	 the	 idea	 that	 susceptible	 individual-restricted	 IEGs	 overexpression	 represents	 a	functional	 biomarker	 of	 stress	 vulnerability[8,10].	However,	 an	 open	 question	 still	 remains	about	 what	 molecular	 players	 could	 orchestrate	 the	 pathway	 modulations	 underlying	 the	divergence	that	occur	at	the	level	of	a	susceptible	or	resilient	hippocampi.	In	 this	 context	we	observed	 that	 SRFD5,	 a	 factor	predicted	 to	 restraining	 susceptibility-like	hippocampal	modifications	 (both	 in	 transcriptional	 and	 structural	 plasticity	 terms)	 plays	 a	role	in	acute	stress	response,	transiently	increasing	its	level	upon	a	paradigm	of	psychosocial	stress.	 In	 this	 regard,	 acute	SRFD5	upregulation	might	play	a	protective	 role.	A	 functionally	convergent	modification	of	 SRF	 corepressor	LSD1	occurs	during	 the	 same	window	of	 acute	
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psychosocial	 stress	 response,	 when	 LSD1	 increases	 through	 a	 splicing-based	 mechanism	aimed	at	reducing	neuroLSD1,	its	dominant	negative	isoform	unable	to	repress	transcription	(also	described	as	a	transcriptional	activator[44])	and	relevant	to	shape	anxiety	behavior[18].	Hence,	SRF	target	genes	transcription	can	be	attenuated	by	combinatorial	assembly	not	only	of	homo-	or	heterodimers	of	SRF	and	SRFD5	(depending	on	their	relative	neuronal	amount)	but	 also	 of	 coregulators	 LSD1/neuroLSD1[18].	 In	 other	 words,	 we	 can	 think	 about	 a	 fine	tuning	mechanism	based	on	corepressor	complex	assembly,	regulated	by	alternative	splicing	of	the	different	components	which,	in	response	to	environmental	stress,	can	exert	a	concerted	homeostatic	action	aimed	at	 restraining	 IEGs	 transcription[12].	 Interestingly	when	stress	 is	chronically	reiterated,	48	hours	after	stress	cessation,	in	resilient	mice	SRF	and	SRFD5	are	not	modified.	 Vice	 versa,	 in	 those	 mice	 that	 develop	 social	 avoidance,	 a	 high	 face	 validity	depressive	 symptom,	 and	 thereby	 defined	 susceptible	 to	 social	 defeat	 stress,	 SRF	 protein	expression	 is	 sustained,	 remaining	 elevated	 after	 stress	 cessation.	 Accordingly,	 its	transcriptional	IEGs	targets	are	as	well	upregulated.	In	this	time	frame,	although	a	tendency	to	SRFD5	 increase	 can	 be	 observed,	 it	 seems	 not	 be	 sufficient	 to	 counteract	 IEGs	 sustained	overexpression.		Global	health	 improvement	 in	western	countries	does	not	encompass	psychiatric	disorders,	whose	 penetrance	 in	 the	 general	 population	 has	 grown	 over	 the	 last	 decades	 overpassing	thresholds	 of	 a	 burden	 for	 healthcare	 national	 systems	 and	 society[65,66].	 Molecular	psychiatry	 research	 has	 concentrated	 huge	 efforts	 to	 shed	 new	 light	 on	 molecular	mechanisms	of	stress-resiliency	and	susceptibility	at	the	basis	of	depression[67].	We	suggest	that	our	discovery	of	a	hippocampus	enriched	repressive	splicing	isoform	of	SRF,	functionally	associated	with	the	histone	H3K4	demethylase	LSD1,	represents	an	important	step	forward	to	better	 understanding	 the	 set	 of	 protective	 processes	 aimed	 at	 buffering	 stimuli-induced	
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plasticity	 gene	 transcription,	 likely	 limiting	 memorization	 of	 negative	 experiences	 via	epigenetically	uncoupling	their	perception	from	inherent	memory	trace	consolidation[12].			
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Figure	Legends	
	Fig.	1	Alternative	splicing-generated	SRFΔ5	is	preferentially	expressed	in	brain	tissues	
and	 modulated	 during	 development.	 A)	 Schematic	 representation	 of	 splicing	 event	generating	 SRFΔ5.	 B)	 Endogenous	 SRF	 and	 SRFΔ5	 proteins	 in	 human,	 rat	 and	 mouse		hippocampus	along	with	Neuro2a	and	HeLa	cell	lines.	Recombinant	myc-tagged	SRF	isoforms.	C)	 SRF	 and	 SRFΔ5	 mRNA	 expression	 in	 different	 non-neuronal	 and	 neuronal	 tissues.	 D)	Electropherogram	from	purified	159bp	SRF-related	band	shows	sequence	of	SRFΔ5	E4	and	E6	splice	 junction	 skipping	 of	 exon	 E5.	 E)	 Histogram	 showing	 SRF	 and	 SRFΔ5	 relative	percentages	 in	 non-neuronal	 and	 neuronal	 tissues.	 F-G)	 Developmental	 modulation	 of	 SRF	and	 SRFΔ5	mRNA	and	protein	 ratio	 in	mouse	 hippocampus.	Data	 are	 presented	 as	mean	±	SEM;	 *,#p<	 0.05,	 **p<	 0.01,	 ***,###p<	 0.001,	 one-way	 ANOVA,	 Bonferroni	 post	 hoc	 test,	 *	referred	to	PN	1-8	group,	#	referred	to	PN	9-15;	(n=3	to	11	mice	per	condition).	H)	Differential	susceptibility	of	endogenous	SRF	and	SRFΔ5	proteins	to	proteasomal	degradation	in	DIV	12	primary	rat	hippocampal	neurons.	Data	are	presented	as	mean	±	SEM;	*p<	0.05,	Student’s	t	test	(n=5	per	condition).		Fig.	2	SRFΔ5	is	unable	to	interact	with	ELK1	co-activator	but	retains	the	ability	to	bind	
LSD1,	along	with	CoREST	and	HDAC2,	and	forms	homo-	and	hetero-dimers	with	SRF.	A)	
	 30	
Schematic	representation	of	SRF	exon	structure,	protein	domain	organization	and	GST-tagged	constructs	used	for	 interactions	analysis,	with	relative	nucleotide	and	amino	acid	extension.	RD	I/II	Repression	Domain	I/II;	NLS	Nuclear	Localization	Signal;	DBD,	DNA-binding	Domain;	TAD	 Transactivation	 Domain.	 B)	 Coomassie	 staining	 of	 bacterially	 expressed	 GST-tagged	proteins.	 C)	 GST	 pull-down	 analysis	 of	 GST-tagged	 SRF	 and	 GST-tagged	 SRFΔ5	 on	 mouse	forebrain	 protein	 extract;	 western	 blot	 images	 showing	 ELK1;	 Syp	 was	 used	 as	 negative	control.	 D)	 GST	 pull-down	 assay	 showing	 GST-SRF,	 GST-SRFΔ5,	 GST-N-SRF	 and	 GST-C-SRF	interactions	with	LSD1,	CoREST	and	HDAC2.	E)	Neuro2a	cells	overexpressing	HA-tagged	and	myc-tagged	SRF	and	SRFΔ5	proteins	show	heterodimers	formation	between	SRF	and	SRFΔ5	isoforms.		Fig.	 3	 SRFΔ5	 negatively	modulates	 neuronal	morphology	 and	 dendritic	 spine	 density	
increasing	 combinatorial	 complexity	 of	 SRF	 repressive	 function.	 A)	 Sholl-based	morphological	analysis	of	GFP-positive	hippocampal	neurons	overexpressing	myc-tagged	SRF	and	SRFΔ5;	neurons	were	 transfected	at	DIV4	and	analyzed	at	DIV8.	Data	are	presented	as	mean	±	SEM;	*p<	0.05,	**p<	0.01	two-way	ANOVA,	Tukey	post	hoc	test	referred	to	control	GFP	group	 B)	 Spine	 density	 analysis	 of	 GFP-positive	 hippocampal	 neurons	 overexpressing	 the	same	constructs	as	in	(A),	neurons	were	transfected	at	DIV4	and	analyzed	at	DIV18.	Data	are	presented	 as	 mean	 ±	 SEM;	 ##p<	 0.01	 ***p<	 0.001,	 one-way	 ANOVA,	 Tukey	 post	 hoc	 test,	*referred	to	GFP	condition,	#referred	to	SRF	condition.	C)	Chemical	LTP	(cLTP)	experiments	were	 performed	 in	 primary	 hippocampal	 neurons	 transfected	 at	 DIV8	with	 GFP,	 and	myc-tagged	 SRF	 and	 SRFΔ5,	 and	 analyzed	 at	DIV18.	 For	 control	 conditions	GFP	was	 used	 along	with	 SRF	 and	 SRFΔ5	 vectors.	 Analyses	 were	 performed	 by	 confocal	 microscopy.	 Data	 are	presented	as	mean	±	SEM;	**p	<	0.01,	****p<	0.0001,	 two-way	ANOVA,	Tukey	post	hoc	 test.	
§p<	 0.05,	 §§p<	 0.01,	 two-way	 ANOVA,	 Tukey	 post	 hoc	 test	 referred	 to	 basal	 GFP	 group.	 D)	
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Nuclear	localization	of	myc-SRF	and	myc-SRFΔ5	proteins	in	DIV18	primary	rat	hippocampal	neurons.		Fig.	4	Acute	Social	Defeat	Stress	(ASDS)	transiently	modifies	relative	abundance	of	SRF	
and	SRFΔ5	proteins	in	the	hippocampus.	A)	Total	SRF	isoforms	mRNA	(assessed	by	qRT-PCR)	and	relative	percentage	of	SRF/SRFΔ5	mRNA	(assessed	with	rqfRT-PCR)	after	2,	7	and	7	hrs	 stress	 +	 24	 hrs	 resting.	 B)	 SRF	 and	 SRFΔ5	 protein	 expression	 profiles	 (evaluated	 by	western	blot)	in	control	mice	and	after	2,	7	and	7	hrs	stress	+	24	hrs	resting.	C)	Stress-induced	transactivation	of	SRF	validated	targets	c-fos,	egr1	and	npas4	in	the	mouse	hippocampus	after	2	and	7	hrs	ASDS	and	after	24	hrs	from	the	cease	of	stress.	Data	are	presented	as	mean	±	SEM;	*p<	 0.05,	 **p<	 0.01,	 one-way	 ANOVA,	 Bonferroni	 post	 hoc	 test.	 	 (n=6	 to	 15	 mice	 per	condition).		Fig.	 5	Chronic	 Social	Defeat	 Stress	 (CSDS)	 stably	modifies	 SRF	and	SRFΔ5	mRNAs	and	
proteins	 in	 the	 hippocampus.	 A)	 Total	 SRF	 isoforms	 mRNA	 (assessed	 by	 qRT-PCR)	 and	relative	percentage	of	SRF/SRFΔ5	mRNA	(assessed	with	rqfRT-PCR)	in	control	mice	and	mice	that	underwent	CSDS	ending	up	in	being	stress-susceptible	(SUS)	of	resilient	(RES)	sorted	by	means	 of	 social	 interaction	 ratio	 (SIR)	 evaluation.	 B)	 SRF	 and	 SRFΔ5	 protein	 expression	profiles	 (evaluated	 by	western	 blot)	 in	 control	mice,	 SUS	 and	 RES.	 All	 the	 gene	 expression	analyses	were	 carried	 out	 after	 48	hrs	 from	 the	 cease	 of	 stress	 paradigm.	 C)	Hippocampus	stable	overexpression	of	SRF	validated	targets	c-fos,	egr1	and	npas4	48	hrs	after	the	cease	of	stress.	 For	 SIR	 see	 table.	Data	 are	 presented	 as	mean	±	 SEM;	 *p<	 0.05,	 **p<	 0.01,	 one-way	ANOVA,	Bonferroni	post	hoc	test,	°p<	0.05	Student’s	t	test.	(ctrl	mice	n=7	SUS	mice	n=6,	RES	mice	n=7).			
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	Fig.	1	Alternative	splicing-generated	SRFΔ5	is	preferentially	expressed	in	brain	tissues	
and	 modulated	 during	 development.	 A)	 Schematic	 representation	 of	 splicing	 event	generating	 SRFΔ5.	 B)	 Endogenous	 SRF	 and	 SRFΔ5	 proteins	 in	 human,	 rat	 and	 mouse		hippocampus	along	with	Neuro2a	and	HeLa	cell	lines.	Recombinant	myc-tagged	SRF	isoforms.	C)	 SRF	 and	 SRFΔ5	 mRNA	 expression	 in	 different	 non-neuronal	 and	 neuronal	 tissues.	 D)	Electropherogram	from	purified	159bp	SRF-related	band	shows	sequence	of	SRFΔ5	E4	and	E6	splice	 junction	 skipping	 of	 exon	 E5.	 E)	 Histogram	 showing	 SRF	 and	 SRFΔ5	 relative	percentages	 in	 non-neuronal	 and	 neuronal	 tissues.	 F-G)	 Developmental	 modulation	 of	 SRF	and	 SRFΔ5	mRNA	and	protein	 ratio	 in	mouse	 hippocampus.	Data	 are	 presented	 as	mean	±	SEM;	 *,#p<	 0.05,	 **p<	 0.01,	 ***,###p<	 0.001,	 one-way	 ANOVA,	 Bonferroni	 post	 hoc	 test,	 *	referred	to	PN	1-8	group,	#	referred	to	PN	9-15;	(n=3	to	11	mice	per	condition).	H)	Differential	susceptibility	of	endogenous	SRF	and	SRFΔ5	proteins	to	proteasomal	degradation	in	DIV	12	primary	rat	hippocampal	neurons.	Data	are	presented	as	mean	±	SEM;	*p<	0.05,	Student’s	t	test	(n=5	per	condition).	
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	Fig.	2	SRFΔ5	is	unable	to	interact	with	ELK1	co-activator	but	retains	the	ability	to	bind	
LSD1,	along	with	CoREST	and	HDAC2,	and	forms	homo-	and	hetero-dimers	with	SRF.	A)	Schematic	representation	of	SRF	exon	structure,	protein	domain	organization	and	GST-tagged	constructs	used	for	 interactions	analysis,	with	relative	nucleotide	and	amino	acid	extension.	RD	I/II	Repression	Domain	I/II;	NLS	Nuclear	Localization	Signal;	DBD,	DNA-binding	Domain;	TAD	 Transactivation	 Domain.	 B)	 Coomassie	 staining	 of	 bacterially	 expressed	 GST-tagged	proteins.	 C)	 GST	 pull-down	 analysis	 of	 GST-tagged	 SRF	 and	 GST-tagged	 SRFΔ5	 on	 mouse	forebrain	 protein	 extract;	 western	 blot	 images	 showing	 ELK1;	 Syp	 was	 used	 as	 negative	control.	 D)	 GST	 pull-down	 assay	 showing	 GST-SRF,	 GST-SRFΔ5,	 GST-N-SRF	 and	 GST-C-SRF	interactions	with	LSD1,	CoREST	and	HDAC2.	E)	Neuro2a	cells	overexpressing	HA-tagged	and	myc-tagged	SRF	and	SRFΔ5	proteins	show	heterodimers	formation	between	SRF	and	SRFΔ5	isoforms.		
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	Fig.	 3	 SRFΔ5	 negatively	modulates	 neuronal	morphology	 and	 dendritic	 spine	 density	
increasing	 combinatorial	 complexity	 of	 SRF	 repressive	 function.	 A)	 Sholl-based	morphological	analysis	of	GFP-positive	hippocampal	neurons	overexpressing	myc-tagged	SRF	and	SRFΔ5;	neurons	were	 transfected	at	DIV4	and	analyzed	at	DIV8.	Data	are	presented	as	
	 35	
mean	±	SEM;	*p<	0.05,	**p<	0.01	two-way	ANOVA,	Tukey	post	hoc	test	referred	to	control	GFP	group	 B)	 Spine	 density	 analysis	 of	 GFP-positive	 hippocampal	 neurons	 overexpressing	 the	same	constructs	as	in	(A),	neurons	were	transfected	at	DIV4	and	analyzed	at	DIV18.	Data	are	presented	 as	 mean	 ±	 SEM;	 ##p<	 0.01	 ***p<	 0.001,	 one-way	 ANOVA,	 Tukey	 post	 hoc	 test,	*referred	to	GFP	condition,	#referred	to	SRF	condition.	C)	Chemical	LTP	(cLTP)	experiments	were	 performed	 in	 primary	 hippocampal	 neurons	 transfected	 at	 DIV8	with	 GFP,	 and	myc-tagged	 SRF	 and	 SRFΔ5,	 and	 analyzed	 at	DIV18.	 For	 control	 conditions	GFP	was	 used	 along	with	 SRF	 and	 SRFΔ5	 vectors.	 Analyses	 were	 performed	 by	 confocal	 microscopy.	 Data	 are	presented	as	mean	±	SEM;	**p	<	0.01,	****p<	0.0001,	 two-way	ANOVA,	Tukey	post	hoc	 test.	§p<	 0.05,	 §§p<	 0.01,	 two-way	 ANOVA,	 Tukey	 post	 hoc	 test	 referred	 to	 basal	 GFP	 group.	 D)	Nuclear	localization	of	myc-SRF	and	myc-SRFΔ5	proteins	in	DIV18	primary	rat	hippocampal	neurons.														
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	Fig.	4	Acute	Social	Defeat	Stress	(ASDS)	transiently	modifies	relative	abundance	of	SRF	
and	SRFΔ5	proteins	in	the	hippocampus.	A)	Total	SRF	isoforms	mRNA	(assessed	by	qRT-PCR)	and	relative	percentage	of	SRF/SRFΔ5	mRNA	(assessed	with	rqfRT-PCR)	after	2,	7	and	7	hrs	 stress	 +	 24	 hrs	 resting.	 B)	 SRF	 and	 SRFΔ5	 protein	 expression	 profiles	 (evaluated	 by	western	blot)	in	control	mice	and	after	2,	7	and	7	hrs	stress	+	24	hrs	resting.	C)	Stress-induced	transactivation	of	SRF	validated	targets	c-fos,	egr1	and	npas4	in	the	mouse	hippocampus	after	2	and	7	hrs	ASDS	and	after	24	hrs	from	the	cease	of	stress.	Data	are	presented	as	mean	±	SEM;	*p<	 0.05,	 **p<	 0.01,	 one-way	 ANOVA,	 Bonferroni	 post	 hoc	 test.	 	 (n=6	 to	 15	 mice	 per	condition).		
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	Fig.	 5	Chronic	 Social	Defeat	 Stress	 (CSDS)	 stably	modifies	 SRF	and	SRFΔ5	mRNAs	and	
proteins	 in	 the	 hippocampus.	 A)	 Total	 SRF	 isoforms	 mRNA	 (assessed	 by	 qRT-PCR)	 and	relative	percentage	of	SRF/SRFΔ5	mRNA	(assessed	with	rqfRT-PCR)	in	control	mice	and	mice	that	underwent	CSDS	ending	up	in	being	stress-susceptible	(SUS)	of	resilient	(RES)	sorted	by	means	 of	 social	 interaction	 ratio	 (SIR)	 evaluation.	 B)	 SRF	 and	 SRFΔ5	 protein	 expression	profiles	 (evaluated	 by	western	 blot)	 in	 control	mice,	 SUS	 and	 RES.	 All	 the	 gene	 expression	analyses	were	 carried	 out	 after	 48	hrs	 from	 the	 cease	 of	 stress	 paradigm.	 C)	Hippocampus	stable	overexpression	of	SRF	validated	targets	c-fos,	egr1	and	npas4	48	hrs	after	the	cease	of	stress.	 For	 SIR	 see	 table.	Data	 are	 presented	 as	mean	±	 SEM;	 *p<	 0.05,	 **p<	 0.01,	 one-way	ANOVA,	Bonferroni	post	hoc	test,	°p<	0.05	Student’s	t	test.	(ctrl	mice	n=7	SUS	mice	n=6,	RES	mice	n=7).				
